Alfuzosin Other names: Alfuzosin hydrochloride

Chemical formula: C₁₉H₂₇N₅O₄  Molecular mass: 389.449 g/mol  PubChem compound: 2092

Therapeutic indications

Alfuzosin is indicated for:

Benign prostatic hypertrophy (BPH)

Population group: men, only adults (18 years old or older)

Treatment of the functional symptoms of benign prostatic hypertrophy (BPH).

For this indication, competent medicine agencies globally authorize below treatments (click for details):


Alfuzosin is contraindicated in the following cases:

Orthostatic hypotension

Orthostatic hypotension

Alpha-1 receptor blockers

Selective α1-adrenergic receptor antagonists

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.